SCYNEXIS, Inc. Proceeds from Issuance of Private Placement
SCYNEXIS, Inc. (SCYX) reported Proceeds from Issuance of Private Placement of $558.00 thousand for the 6-month period ending 2016-06-30, per its 10-Q filed 2016-08-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2016-08-08
- 2016-06-30: Proceeds from Issuance of Private Placement 6 month $558.00K.
- 2015-06-30: Proceeds from Issuance of Private Placement 6 month $0.00.
| Period end | Proceeds from Issuance of Private Placement 6 month |
|---|---|
| 2016-06-30 | $558.00K 10-Q · filed 2016-08-08 |
| 2015-06-30 | $0.00 10-Q · filed 2016-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |